AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Fagron N.V.

Quarterly Report Aug 3, 2023

3949_rns_2023-08-03_c760e518-79e9-4342-9e24-d13cdb5418ab.pdf

Quarterly Report

Open in Viewer

Opens in native device viewer

Interim Financial Statements First semester of 2023

Contents

1. Interim management report
3. Condensed consolidated statement of comprehensive income
4. Condensed consolidated statement of financial position
5. Condensed consolidated statement of changes in equity
6. Condensed consolidated cash flow statement
7. Notes to the interim financial information
8. Other operating income
9. Services and other goods
$11. \;Non-recurring result. \label{prop:non-1} \dots \dots \dots \dots \dots \dots \dots \dots \dots \dots \dots \dots \dots \dots \dots \dots \dots \dots \dots$
12. Segment information
.
13. Goodwill……………………………………………………………………………………………
14. Debt ………………………………………………………………………………………………
16. Total adjustments for non-cash items
17. Total changes in working capital
18. Business combination
19. Related parties
20. Subsequent events
21. Effective tax rate
22. Alternative performance measures

The undersigned hereby declare that, to the best of their knowledge, the condensed consolidated financial statements for the six-month period ended 30 June 2023, which have been prepared in accordance with IAS 34 'Interim Financial Reporting' as adopted by the European Union, give a true and fair view of the assets, liabilities, financial position and profit and loss of the company and the undertakings included in the consolidation as a whole, and that the interim management report includes a fair review of the important events that have occurred during the first semester of the financial year and of other legal necessary information.

Rafael Padilla, CEO Karin de Jong, CFO

1. Interim management report

A detailed report on the development in the first six months of 2023 can be found in Fagron's press release of 3 August 2023.

2. Condensed consolidated income statement

(x 1,000 euros) Note June 2023 June 2022
Operating income 372,456 331,221
Revenue 371,573 328,565
Other operating income 8 882 2,656
Operating expenses 319,727 284,419
Trade goods 145,973 138,199
Services and other goods 9 62,712 54,033
Employee benefit expenses 90,674 74,030
Depreciation and amortization 18,958 15,720
Other operating expenses 1,410 2,437
Operating profit 52,728 46,801
Financial income 14 2,465 5,130
Financial expenses 14 -13,011 -7,316
Profit before income tax 42,182 44,615
Taxes 21 8,901 9,317
Net-profit (loss) 33,282 35,299
Attributable to:
Shareholders of the company (net profit) 33,037 35,166
Non-controlling interest(s) 244 132
Profit (loss) per share attributable to the shareholders during
the period
Profit (loss) per share (in euros) 10 0.45 0.48
Diluted profit (loss) per share (in euros) 10 0.45 0.48

3. Condensed consolidated statement of comprehensive income

(x 1,000 euros) Note June 2023 June 2022
Net profit (loss) for the period 33,282 35,299
Other comprehensive income:
Items that may be subsequently reclassified to profit or loss
Interest hedge 14 962 2,744
Currency translation differences 11,166 26,927
Other comprehensive income for the period 12,128 29,672
Total comprehensive income for the period 45,409 64,970
Attributable to:
Shareholders of the company 45,215 64,813
Non-controlling interest(s) 195 158

The unrealized currency translation differences of 11.2 million euros in the first six months of 2023 are mainly due to the strengthening of the Brazilian real against the euro at 31 December 2022.

The unrealized currency translation differences in the first six months of 2022 of 26.9 million euros were mainly due to the strengthening of the Brazilian real against the euro at 31 December 2021.

4. Condensed consolidated statement of financial position

(x 1,000 euros) Note June 2023 December 2022
Non-current assets 668,727 653,000
Goodwill 13 437,396 429,768
Intangible assets 40,232 33,633
Property, plant and equipment 111,262 104,086
Leasing and similar rights 37,745 39,510
Financial assets 4,252 4,210
Financial Instruments 7,455 13,277
Other non-current fixed assets 3,651 3,731
Deferred tax assets 26,735 24,785
Current assets 355,991 318,010
Inventories 127,161 108,337
Trade receivables 76,965 60,722
Financial instruments 6,808 451
Other receivables 32,844 23,163
Cash and cash equivalents 112,213 125,337
Total assets 1,024,719 971,010
Equity 440,526 410,518
Shareholders' equity (parent) 436,372 404,541
Non-controlling interest(s) 4,155 5,977
Non-current liabilities 383,396 389,484
Provisions 2,208 2,024
Pension obligations 2,719 2,739
Deferred tax liabilities 2,694 4,352
Debt 14 344,509 346,673
Lease Liabilities 31,266 33,697
Current liabilities 200,796 171,009
Debt 14 11 9,461
Lease liabilities 9,712 9,548
Trade payables 119,318 97,856
Tax liabilities for the current year 9,895 7,993
Other current taxes, remuneration and social security 36,377 30,777
Other current payables 18 24,126 15,191
Financial instruments 1,357 181
Total liabilities 584,192 560,493
Total equity and liabilities 1,024,719 971,010

5. Condensed consolidated statement of changes in equity

(x 1,000 euros) Share
capital &
share
premium
Other
reserves
Cash flow
hedge
reserve
Treasury
shares
Retained
earnings
Total Non
control
ling
interest
Total
equity
Balance as of 1 January
2022
520,785 -277,154 -18,823 95,297 320,105 5,361 325,466
Profit (loss) for the period 35,166 35,166 132 35,299
Other comprehensive income 29,647 29,647 25 29,672
Total comprehensive
income for the period
29,647 35,166 64,813 158 64,970
Capital increase 453 453 453
Declared dividends -14,592 -14,592 -14,592
Share-based payments 1,079 1,079 1,079
Balance as of 30 June 2022 521,238 -246,428 -18,823 115,872 371,859 5,519 377,377
Profit (loss) for the period 34,445 34,445 322 34,767
Other comprehensive income -9,868 7,384 -2,484 136 -2,347
Total comprehensive
income for the period
-9,868 7,384 34,445 31,962 458 32,420
Capital increase
Declared dividends
Share-based payments 720 720
Balance as of 31 December
2022
521,238 -255,576 7,384 -18,823 150,317 404,541 5,977 410,518
Profit (loss) for the period 33,037 33,037 244 33,282
Other comprehensive income 11,215 962 12,177 -50 12,128
Total comprehensive
income for the period
11,215 962 33,037 45,215 195 45,409
Capital increase 3,293 3,293 3,293
Declared dividends -18,175 -18,175 -18175
Share-based payments 1,232 1,232 1,232
Acquisition of non-controlling
interests
266 266 -2,017 -1,751
Balance as of 30 June 2023 524,531 -242,862 8,346 -18,823 165,180 436,372 4,155 440,526

6. Condensed consolidated cash flow statement

(x 1,000 euros)
Note
June 2023 June 2022
Operating activities
Profit before income taxes 42,182 44,615
Taxes paid -11,189 -8,731
Adjustments for financial items 10,546 2,186
Total adjustments for non-cash items 16 20,058 16,139
Total changes in working capital 17 -18,322 -15,622
Total cash flow from operating activities 43,275 38,587
Investment activities
Capital expenditure -20,984 -6,681
Investments in existing shareholdings (subsequent payments)
and in new holdings
-5,542 -46,638
Proceeds from sold shareholdings 3,226
Total cash flow from investment activities -26,526 -50,094
Financing activities
Capital increase 3,293 453
Dividends paid -13,086 -9,955
New debt 135,000
Reimbursement of debt -10,437 -65,122
Payment of lease obligations -5,743 -4,523
Interest received 2,893 990
Interest paid -9,456 -6,013
Total cash flow from financing activities -32,535 50,830
Total net cash flow for the period -15,787 39,323
Cash and cash equivalents – start of the period 125,337 70,646
Gains (losses) from currency translation differences 2,662 4,026
Cash and cash equivalents – end of the period 112,213 113,996
Changes in cash and cash equivalents -15,787 39,323

7. Notes to the interim financial information

1. General information

Fagron is a leading global company active in pharmaceutical compounding, focusing on delivering personalized medicine to hospitals, pharmacies, clinics, and patients in more than 30 countries around the world.

The Belgian company Fagron NV has its registered office in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol 'FAGR'. Fagron's operational activities are managed by the Dutch company Fagron BV, which is headquartered in Rotterdam.

These condensed consolidated financial statements were approved for publication by the Board of Directors on 1 August 2023.

In the event of differences between the English translation and the Dutch original of the interim financial statements, the latter prevails.

2. Summary of the most important basis for the condensed consolidated interim financial information

This condensed consolidated interim financial information for the first six months of 2023, including the comparative figures for 2022, has been prepared in accordance with IAS 34 'Interim Financial Reporting' as adopted by the European Union. The condensed consolidated interim financial information must be read in conjunction with the 2022 annual report (including the principles for financial reporting) which is available at www.fagron.com.

3. Summary of the most important accounting policies

The most important accounting policies used to prepare the condensed consolidated interim financial statements for the first semester of 2023 are consistent with those applied in the Fagron consolidated financial statements for the year ended 31 December 2022.

A summary of the most important accounting policies can be found in the 2022 annual report. The annual report can be consulted on www.fagron.com.

This condensed consolidated interim financial information has been prepared in accordance with IFRS standards and IFRIC interpretations that apply, or which are applied early, as of 30 June 2023 and which have been endorsed by the European Union.

Standards and interpretations applicable for the annual period beginning on or after 1 January 2023

  • IFRS 17 Insurance Contracts
  • Amendments to IFRS 17 Insurance contracts: Initial Application of IFRS 17 and IFRS 9 Comparative Information
  • Amendments to IAS 1 Presentation of Financial Statements and IFRS Practice Statement 2: Disclosure of Accounting Policies
  • Amendments to IAS 8 Accounting policies, Changes in Accounting Estimates and Errors: Definition of Accounting Estimates
  • Amendments to IAS 12 Income Taxes: Deferred Tax related to Assets and Liabilities arising from a Single Transaction

• Amendments to IAS 12 Income taxes: International Tax Reform – Pillar Two Model Rules (effective immediately but not yet endorsed in the EU – disclosures are required for annual periods beginning on or after 1 January 2023)

Standards and interpretations published, but not yet applicable for the annual period beginning on 1 January 2023:

  • Amendments to IAS 1 Presentation of Financial Statements: Classification of Liabilities as Current or Noncurrent and Noncurrent Liabilities with Covenants (applicable for annual periods beginning on or after 1 January 2024, but not yet endorsed in the EU)
  • Amendments to IFRS 16 Leases: Lease Liability in a Sale and Leaseback (applicable for annual periods beginning on or after 1 January 2024, but not yet endorsed in the EU).
  • Amendments to IAS 7 Statement of Cash Flows and IFRS 7 Financial Instruments: Disclosures: Supplier Finance Arrangements (applicable for annual periods beginning on or after 1 January 2024, but not yet endorsed in the EU)

Fagron has determined that the application of these changes to these standards does not have any material effect on these interim financial statements.

4. Seasonality

Revenue and operating profit of Fagron are limitedly impacted by seasonal influences.

8. Other operating income

Decrease of other operating income is mainly due to a release of contingent obligations in 2022 related to acquisitions in North America.

9. Services and other goods

(x 1,000 euros) June 2023 June 2022
Sales and distribution costs 21,269 20,188
Contracted services 16,025 13,316
Other services and goods 25,417 20,529
Total services and other goods 62,712 54,033

Other services and goods cover a wide range of services and goods such as maintenance, utilities, office supplies and travel costs.

10. Profit per share

(x 1 euro) June 2023 June 2022
Basic profit (loss) per share 0.45 0.48
Diluted profit (loss) per share 0.45 0.48

The profit used in the calculations are as follows:

(x 1,000 euros) June 2023 June 2022
Profit (loss) attributable to the shareholders of the company 33,037 35,166

The weighted average number of ordinary shares used in the calculations is as follows:

(Number of shares x 1,000) June 2023 June 2022
Weighted average number of ordinary shares 72,966 72,860
Effect of warrants and stock options - 40
Weighted average number of ordinary shares (diluted) 72,966 72,901

On 30 June 2023, the capital represented 73,228,904 shares, of which 103,627 are treasury shares held by Fagron NV.

11. Non-recurring result

A non-recurring item is an event or transaction that is considered abnormal, not related to ordinary company activities, and unlikely to recur in the foreseeable future. This can be a gain or a loss. The total non-recurring profit included in EBITDA amounts to -0.5 million euros (June 2022: -0.8 million euros). Which mainly included legal costs and restructuring costs. In 2022 non-recurring costs mainly included acquisition costs, restructuring costs and a release of contingent consideration related to acquisitions in North America.

12. Segment information

Fagron's divisional structure is tailored to the various activities of Fagron and supports also effective decisionmaking and individual responsibility. This is in accordance with IFRS 8, which states that the operational segments must be determined based on the components used by the Executive Leadership Team to assess the performance of the operational activities and on which the decisions are based. Fagron reports according to the following segments: Fagron EMEA, Fagron North America, and Fagron Latin America.

The segment results for the reporting period ending 30 June 2023 are as follows:

(x 1,000 euros) Fagron
EMEA
Fagron
North
America
Fagron Latin
America
Total
Revenue 146,084 145,039 80,450 371,573
Intersegment revenue 646 80 82 809
Total revenue 146,730 145,119 80,532 372,381
Operating profit per segment 25,652 18,326 8,750 52,728
Financial result -10,546
Profit before income tax 42,182
Taxes 8,901
Net profit (loss) 33,282

The segment results for the reporting period ending 30 June 2022 are as follows:

(x 1,000 euros) Fagron
EMEA
Fagron
North
America
Fagron
Latin
America
Total
Revenue 137,709 112,294 78,561 328,565
Intersegment revenue 553 81 154 789
Total revenue 138,263 112,375 78,715 329,353
Operating profit per segment 22,245 14,216 10,340 46,801
Financial result -2,186
Profit before income tax 44,615
Taxes 9,317
Net profit (loss) 35,299

A detailed explanation of the segment profit and disaggregated revenue are provided in the press release of 3 August 2023.

(x 1,000 euros) Fagron
EMEA
Fagron
North
America
Fagron
Latin
America
Unallocated
/inter
segment
elimination
Total
Total assets 400,255 324,155 220,720 79,589 1,024,719
Total liabilities 148,296 216,941 52,612 166,343 584,192
Capital expenditure 9,524 10,395 2,823 22,742

On 30 June 2023, the assets and liabilities, as well as the capital expenditures (investments) are as follows:

On 31 December 2022, the assets and liabilities, as well as the capital expenditures (investments) are as follows:

(x 1,000 euros) Fagron
EMEA
Fagron
North
America
Fagron
Latin
America
Unallocated
/inter
segment
elimination
Total
Total assets 389,344 317,010 206,270 58,387 971,010
Total liabilities 142,593 215,830 52,487 149,583 560,493
Capital expenditure 8,266 6,920 5,291 0 20,477

Gross capital expenditures in the first half of 2023 mainly relate to investments in registration and exclusive distribution and licensing rights in the Benelux of some products, investments in the Tampa facility in the United States and further software implementations. The investment expenditure excludes the change in investment obligations. The unallocated assets mainly relate to cash and cash equivalents. The unallocated liabilities mainly relate to financial debts.

13. Goodwill

The increase in goodwill is explained by business combinations as further explained in note 18 and exchange rate differences mainly caused by a weakening of the US dollar and a strengthening of the Brazilian real against the euro as per 31 December 2022.

14. Debt

On 30 June 2023, the outstanding amount of both term loans was a total of 235 million euros (December 2022: 235 million euros) and an amount of 110.4 million euros has been drawn under the syndicated credit line (December 2022: 112.5 million euros).

During the first six months of 2023 no changes have been made to the interest hedge portfolio. The interest rate risk related to 180 million euros of term loans was hedged with interest derivatives. The duration of the euro interest hedges varies from August 2023 until August 2025. The interest hedge related to the interest exposure on 100 million US dollars has remained unchanged and has an end date of June 2024.

All financial instruments are valued at amortised cost except for derivative financial instruments and contingent considerations for acquisitions, which are valued at fair value. The fair value approximates the carrying amount. The interest hedge for 180 million euro related to the long term debt is accounted for under the IFRS hedge accounting rules, resulting in (re-)valuation through equity.

The (re-)valuation of the financial derivatives through the financial result was 1.4 million euros in financial costs (June 2022: 4.2 million euros financial income) from interest rate derivatives and 2.0 million euros (June 2022: 2.2 million euros) in financial costs from currency derivatives. The 2.0 million euros in financial costs due to the

(re-)valuation of the currency derivatives are largely offset by income from exchange rate differences. The remaining increase in the financial expenses mainly relate to higher interest expenses.

On 30 June 2023, the net financial debt / EBITDA ratio equals 1.88 The EBITDA / net interest expense ratio is equal to 7.58. Fagron thus more than met the financial covenants.

15. Contingencies

Fagron faces certain risks for which no provision has been made because it is unlikely that these risks will have a negative impact for Fagron. In July 2018 and August 2021, Fagron received a tax assessment regarding the amortization of goodwill due to mergers in Brazil. The tax authorities opened a new assessment in April 2023. We dispute these assessments in the total amount of 32.8 million euros and have not made any provision for this purpose. There were no other material changes.

16. Total adjustments for non-cash items

(x 1,000 euros) June 2023 June 2022
Amortisation of intangible fixed assets 5,348 4,370
Depreciation of property, plant and equipment 5,618 4,996
Depreciation of lease and similar rights 5,566 4,970
Write down on inventories and receivables 2,425 1,385
Profit (Loss) on sale of fixed assets -141 -651
Movements in provisions 9 -10
Share-based payments 1,232 1,079
Total adjustments for non-cash items 20,058 16,139

17. Total changes in working capital

(x 1,000 euros) June 2023 June 2022
Changes in operational working capital -14,119 -14,116
Changes in other working capital -4,203 -1,506
Total changes in working capital -18,322 -15,662

18. Business combination

Fair value of acquired assets and liabilities

The provisional determination of the fair value of assets acquired and liabilities assumed in the Wildlife Pharmaceutical acquisition in South Africa resulted in an adjustment of 4.0 million euros to goodwill.

The final determination of the fair value of assets acquired and liabilities assumed from prior acquisitions in 2022 resulted in an adjustment of 0.5 million euros to goodwill.

Contingent considerations

On 30 June 2023, Fagron had 5.5 million euros in contingencies. These fees payable to former shareholders were determined based on business plans at the time of acquisition.

The deferred payments and contingent considerations for business combinations relate to acquisitions in the Netherlands, Germany and South-Africa and vary between 0 euros and a maximum of 5.5 million euros. It is expected that these will be paid in 2023 and 2024.

The considerations are measured at the fair value at acquisition date. This is estimated based on the maximum compensation if the conditions are met.

19. Related parties

The members of the Executive Leadership Team and the non-executive directors are considered as related parties. The remuneration policy is described in the Corporate Governance Statement which is part of the 2022 annual report and the Remuneration policy directors and executive leadership team available on www.fagron.com. The remuneration is determined on a yearly basis; therefore, no further details are provided in these interim financial statements.

In the first half of 2023, 138,372 performance shares and 134,271 performance share units were granted to Fagron's executive leadership team and employees. The performance objectives are based on a combination of financial objectives and sustainability objectives. Financial objectives for the first grant under the plan for 2022- 2024 relate to relative total shareholder return (TSR), organic revenue growth, REBITDA, and operational cash conversion. Sustainability objectives for the first grant under the plan for the period 2022-2024, relate to the reduction of greenhouse gas intensity and employee engagement.

20. Subsequent events

In July 2023, a change has been made to the interest hedge portfolio. The interest rate risk related to 20 million euros of term loans was hedged with an interest derivative. The duration of the euro interest hedge is 3 year until August 2026 and replaces an interest derivative of 30 million euros with a duration date till August 2023.

21. Effective tax rate

Recognised income tax expenses are based on management's best estimate of the weighted average effective income tax rate of 21.1% for 2023 (S1 2022: 20.9%).

22. Alternative performance measures

In addition to the performance measures defined in IFRS, other measures are also used in these interim financial statements. These "alternative performance measures" are set out below:

(x 1,000 euros) June 2023 June 2022
Operating profit (EBIT) 52,728 46,801
Depreciation and amortization 18,958 15,720
EBITDA 71,686 62,522
EBITDA 71,686 62,522
Non-recurring profit 497 800
REBITDA 72,183 63,322
(x 1.000 euro)
Total cash flow from operating activities 43,275 38,587
Capital expenditures -20,984 -6,681
Free cash flow 22,291 31,906
(x 1,000 euros) June 2023 December 2022
Net financial debt
Debt- non-current 344,509 346,673
Lease liabilities - non-current 31,266 33,697
Debt- current 11 9,461
Lease liabilities - current 9,712 9,548
Cash and cash equivalents 112,213 125,337
Total net financial debt 273,285 274,042
Inventories 127,161 108,337
Trade receivables 76,965 60,722
Trade payables -119,318 -97,856
Operational working capital 84,809 71,203

Fagron NV Document subtitle= Verdana Heading 12 0/0 single

Fagron NV

Report on the review of the consolidated interim financial information for the six-month period ended 30 June 2023

The original text of this report is in Dutch

Report on the review of the consolidated interim financial information of Fagron NV for the six-month period ended 30 June 2023

In the context of our appointment as the company's statutory auditor, we report to you on the consolidated interim financial information. This consolidated interim financial information comprises the condensed consolidated statement of financial position as at 30 June 2023, the condensed consolidated income statement, the condensed consolidated statement of comprehensive income, the condensed consolidated statement of changes in equity and the condensed consolidated statement of cash flows for the period of six months then ended, as well as selective notes 7 to 22.

Report on the consolidated interim financial information

We have reviewed the consolidated interim financial information of Fagron NV ("the company") and its subsidiaries (jointly "the group"), prepared in accordance with International Accounting Standard (IAS) 34, "Interim Financial Reporting" as adopted by the European Union.

The consolidated condensed statement of financial position shows total assets of 1 024 719 (000) EUR and the consolidated condensed income statement shows a net profit for the period then ended of 33 282 (000) EUR.

The board of directors of the company is responsible for the preparation and fair presentation of the consolidated interim financial information in accordance with IAS 34, "Interim Financial Reporting" as adopted by the European Union. Our responsibility is to express a conclusion on this consolidated interim financial information based on our review.

Scope of review

We conducted our review of the consolidated interim financial information in accordance with International Standard on Review Engagements (ISRE) 2410, "Review of interim financial information performed by the independent auditor of the entity". A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit performed in accordance with the International Standards on Auditing (ISA) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion on the consolidated interim financial information.

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the consolidated interim financial information of Fagron NV has not been prepared, in all material respects, in accordance with IAS 34, "Interim Financial Reporting" as adopted by the European Union.

Signed at Antwerp.

The statutory auditor

Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises BV/SRL Represented by Ine Nuyts

Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises BV/SRL Registered Office: Gateway building, Luchthaven Brussel Nationaal 1 J, B-1930 Zaventem VAT BE 0429.053.863 - RPR Brussel/RPM Bruxelles - IBAN BE86 5523 2431 0050 - BIC GKCCBEBB

Talk to a Data Expert

Have a question? We'll get back to you promptly.